Myriad Genetics Says Will Present Data on BRACAnalysis CDx(TM), HRD(TM) at 2014 ASCO Meeting

By: via Benzinga
Myriad Genetics, Inc. (Nasdaq: MYGN), a global leader in molecular diagnostics, announced the presentation of new data at the American ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.